AbCellera Biologics
(NASDAQ) ABCL
AbCellera Biologics Financials at a Glance
Market Cap
$1.07B
Revenue (TTM)
$75.13M
Net Income (TTM)
$146.41M
EPS (TTM)
$-0.49
P/E Ratio
-7.20
Dividend
$0.00
Beta (Volatility)
1.32 (Average)
Dividend
$0.00
Beta (Volatility)
1.32 (Average)
Price
$3.42
Volume
66,900
Open
$3.53
Price
$3.42
Volume
66,900
Open
$3.53
Previous Close
$3.42
Daily Range
$3.40 - $3.58
52-Week Range
$1.89 - $6.51
Dividend
$0.00
Beta (Volatility)
1.32 (Average)
Price
$3.42
Volume
66,900
Open
$3.53
Previous Close
$3.42
Daily Range
$3.40 - $3.58
52-Week Range
$1.89 - $6.51
ABCL News
ABCL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout AbCellera Biologics
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
562
CEO
Carl Lars G. Hansen, PhD
Website
www.abcellera.comHeadquarters
Vancouver, BC V5Y 0A1, CA
ABCL Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-3%
Net Income Margin
-2%
Return on Equity
-14%
Return on Capital
-17%
Return on Assets
-11%
Earnings Yield
-13.89%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.07B
Shares Outstanding
303.16M
Volume
66.90K
Short Interest
0.00%
Avg. Volume
4.12M
Financials (TTM)
Gross Profit
$75.13M
Operating Income
$217.10M
EBITDA
$155.42M
Operating Cash Flow
$131.29M
Capital Expenditure
$42.77M
Free Cash Flow
$174.07M
Cash & ST Invst.
$560.33M
Total Debt
$143.22M
AbCellera Biologics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$44.85M
+788.2%
Gross Profit
$44.85M
+788.2%
Gross Margin
100.00%
N/A
Market Cap
$1.07B
N/A
Market Cap/Employee
$1.80M
N/A
Employees
596
N/A
Net Income
$8.95M
+73.9%
EBITDA
$18.23M
+67.0%
Quarterly Fundamentals
Net Cash
$417.11M
-25.5%
Accounts Receivable
$153.40M
+66.5%
Inventory
$6.34M
N/A
Long Term Debt
$137.40M
+126.2%
Short Term Debt
$5.82M
+25.8%
Return on Assets
-10.79%
N/A
Return on Invested Capital
-16.80%
N/A
Free Cash Flow
$44.59M
-88.7%
Operating Cash Flow
$34.74M
-334.3%